Show simple item record

dc.contributor.authorAldrugh, Summer
dc.contributor.authorSardana, Mayank
dc.contributor.authorHenninger, Nils
dc.contributor.authorSaczynski, Jane S.
dc.contributor.authorMcManus, David D.
dc.date2022-08-11T08:11:02.000
dc.date.accessioned2022-08-23T17:29:24Z
dc.date.available2022-08-23T17:29:24Z
dc.date.issued2017-08-01
dc.date.submitted2018-06-11
dc.identifier.citation<p>J Cardiovasc Electrophysiol. 2017 Aug;28(8):958-965. doi: 10.1111/jce.13261. Epub 2017 Jun 21. <a href="https://doi.org/10.1111/jce.13261">Link to article on publisher's site</a></p>
dc.identifier.issn1045-3873 (Linking)
dc.identifier.doi10.1111/jce.13261
dc.identifier.pmid28569383
dc.identifier.urihttp://hdl.handle.net/20.500.14038/50311
dc.description.abstractAtrial fibrillation (AF) is one of the most common types of cardiac arrhythmia, particularly among older adults. AF confers a 5-fold risk for thromboembolic stroke as well as a 2-fold higher risk for congestive heart failure, morbidity, and mortality. Although stroke remains an important and impactful complication of AF, recent studies have shown that AF is independently associated with other neurological disorders, including cognitive impairment and dementia, even after adjusting for prior ischemic stroke. We performed a review of the published literature on the association between AF and cognitive status. Further, we reviewed studies investigating the underlying mechanisms for this association and/or reporting the impact of AF treatment on cognitive function. While most published studies demonstrate associations between AF and impaired cognition, no AF treatment has yet been associated with a reduced incidence of cognitive decline or dementia.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28569383&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1111/jce.13261
dc.subjectUMCCTS funding
dc.subjectAlzheimer's disease
dc.subjectanticoagulants
dc.subjectatrial fibrillation
dc.subjectcognitive decline
dc.subjectdementia
dc.subjectvascular dementia
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectMental Disorders
dc.subjectNervous System Diseases
dc.subjectNeurology
dc.subjectPathological Conditions, Signs and Symptoms
dc.subjectTranslational Medical Research
dc.titleAtrial fibrillation, cognition and dementia: A review
dc.typeJournal Article
dc.source.journaltitleJournal of cardiovascular electrophysiology
dc.source.volume28
dc.source.issue8
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/umccts_pubs/139
dc.identifier.contextkey12289586
html.description.abstract<p>Atrial fibrillation (AF) is one of the most common types of cardiac arrhythmia, particularly among older adults. AF confers a 5-fold risk for thromboembolic stroke as well as a 2-fold higher risk for congestive heart failure, morbidity, and mortality. Although stroke remains an important and impactful complication of AF, recent studies have shown that AF is independently associated with other neurological disorders, including cognitive impairment and dementia, even after adjusting for prior ischemic stroke. We performed a review of the published literature on the association between AF and cognitive status. Further, we reviewed studies investigating the underlying mechanisms for this association and/or reporting the impact of AF treatment on cognitive function. While most published studies demonstrate associations between AF and impaired cognition, no AF treatment has yet been associated with a reduced incidence of cognitive decline or dementia.</p>
dc.identifier.submissionpathumccts_pubs/139
dc.contributor.departmentDepartment of Psychiatry
dc.contributor.departmentDepartment of Neurology
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.source.pages958-965


This item appears in the following Collection(s)

Show simple item record